INTS9 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.100100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.559800E-02
Normal-vs-Stage2
4.255800E-03
Normal-vs-Stage3
5.603600E-02
Normal-vs-Stage4
1.555970E-01
Stage1-vs-Stage2
8.423400E-01
Stage1-vs-Stage3
2.844000E-01
Stage1-vs-Stage4
5.120400E-01
Stage2-vs-Stage3
2.683200E-01
Stage2-vs-Stage4
4.285400E-01
Stage3-vs-Stage4
1.881390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.917000E-03
Normal-vs-AfricanAmerican
1.720960E-01
Normal-vs-Asian
2.753600E-02
Caucasian-vs-AfricanAmerican
5.190800E-01
Caucasian-vs-Asian
7.827600E-01
AfricanAmerican-vs-Asian
5.276400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.819300E-03
Normal-vs-Female
5.897700E-03
Male-vs-Female
6.805800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.568000E-02
Normal-vs-Age(41-60Yrs)
2.939000E-03
Normal-vs-Age(61-80Yrs)
1.457910E-02
Normal-vs-Age(81-100Yrs)
6.776400E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.907400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.097600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.957400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.184600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.682800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.869600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.021900E-03
Normal-vs-Daily Drinker
2.843800E-02
Normal-vs-Weekly Drinker
3.929900E-02
Normal-vs-Occasional Drinker
1.823660E-02
Normal-vs-Social Drinker
1.721900E-02
Non Drinker-vs-Daily Drinker
2.544000E-01
Non Drinker-vs-Weekly Drinker
7.982400E-02
Non Drinker-vs-Occasional Drinker
1.365030E-01
Non Drinker-vs-Social Drinker
2.227700E-02
Daily Drinker-vs-Weekly Drinker
5.559800E-01
Daily Drinker-vs-Occasional Drinker
7.866600E-01
Daily Drinker-vs-Social Drinker
3.368400E-01
Weekly Drinker-vs-Occasional Drinker
7.077000E-01
Weekly Drinker-vs-Social Drinker
7.393000E-01
Occasional Drinker-vs-Social Drinker
4.348600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.731800E-01
Normal-vs-Grade 2
6.877700E-02
Normal-vs-Grade 3
7.894000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.821600E-01
Grade 1-vs-Grade 3
6.513800E-01
Grade 1-vs-Grade 4
2.731800E-01
Grade 2-vs-Grade 3
7.364400E-01
Grade 2-vs-Grade 4
6.877700E-02
Grade 3-vs-Grade 4
7.894000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.656700E-03
Normal-vs-NonDiabetic
6.376900E-03
Diabetic-vs-NonDiabetic
5.347800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.994000E-02
Normal-vs-NoPancreatitis
6.063600E-03
Pancreatitis-vs-NoPancreatitis
5.432600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.633970E-02
Normal-vs-N1
4.564500E-03
N0-vs-N1
9.165600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.159570E-02
Normal-vs-TP53-NonMutant
6.560000E-02
TP53-Mutant-vs-TP53-NonMutant
3.214200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
